Sirolimus‐eluting stent implantation for treatment of proximal left anterior descending coronary artery lesions: Long‐term outcome and predictors of adverse cardiac events

Abstract

SES implantation for proximal LAD disease appears safe and effective in a real-world population, and the independent predictors of MACE included stented length and left ventricular dysfunction.

Deployment of drug‐eluting stents for isolated proximal lad disease is associated with lower major adverse cardiac events and no increase in stent thrombosis when compared with bare metal stents: A 5‐year observational cohort study

“…Drug eluting stents (DES) are now widely used in preference to bare metal stents (BMS) for elective and emergency percutaneous coronary intervention (PCI), due to reduced rates of clinical and angiographic restenosis . However, there remain concerns about late DES thrombosis, which, although infrequent with contemporary antiplatelet regimens, is associated with acute coronary occlusion and high morbidity and mortality .…”